Department of Infectious Diseases, Kobe City Medical Center General Hospital, Japan; Department of General Internal Medicine, Kobe City Medical Center General Hospital, Japan.
Department of Infectious Diseases, Kobe City Medical Center General Hospital, Japan; Department of General Internal Medicine, Kobe City Medical Center General Hospital, Japan.
Int J Infect Dis. 2020 Sep;98:297-298. doi: 10.1016/j.ijid.2020.06.050. Epub 2020 Jun 17.
Adenosine deaminase (ADA) in cerebrospinal fluid (CSF) is considered to be a useful biomarker in differentiating tuberculous meningitis (TBM) from other meningitis in non-HIV patients. However, its specificity decreases in patients with HIV, and other diseases such as cytomegalovirus encephalitis, toxoplasmosis or meningeal lymphomatosis can also elevate ADA in CSF. We here report a rare case of retroviral rebound syndrome in a HIV patient, whose ADA in CSF was elevated.
脑脊液中的腺苷脱氨酶(ADA)被认为是鉴别非 HIV 患者结核性脑膜炎(TBM)与其他脑膜炎的有用生物标志物。然而,在 HIV 患者中其特异性降低,其他疾病如巨细胞病毒性脑炎、弓形虫病或脑膜淋巴瘤也可使 CSF 中的 ADA 升高。我们在此报告一例 HIV 患者罕见的逆转录病毒反弹综合征病例,其脑脊液中的 ADA 升高。